Get started
AbbVie, Inc.AbbVie, Inc.AbbVie, Inc.

AbbVie, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals Bonds

ABBV chart


Full chart

Key facts today


AbbVie settled litigation with generic drugmakers over Rinvoq, extending patent protection until April 2037. Rinvoq's sales may exceed $12 billion, boosting AbbVie shares to a record $223.
AbbVie announced positive Phase 3 results for Rinvoq in alopecia areata and will pursue regulatory approval, with more Phase 3 results for other conditions expected soon.
Analyze the impactAnalyze the impact

ABBV upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪373.87 B‬ USD
Dividend yield (indicated)
3.10%
Price to earnings Ratio (TTM)
92.09
Basic EPS (TTM)
2.11 USD
Net income (FY)
‪4.24 B‬ USD
Revenue (FY)
‪56.33 B‬ USD
Shares float
‪1.76 B‬
Beta (1Y)
0.36

Employees


Employees (FY)
‪55 K‬
Change (1Y)
‪+5 K‬ +10.00%
Revenue / Employee (1Y)
‪1.02 M‬ USD
Net income / Employee (1Y)
‪77.05 K‬ USD

About AbbVie Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Robert A. Michael
Website
abbvie.com
Headquarters
North Chicago
Founded
2011
ISIN
US00287Y1091
FIGI
BBG01LGTZ0N7
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Check out other big names from the same industry as ABBV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ABBV news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ABBV highest yielding bonds


ABBV5759202
AbbVie Inc. 4.95% 15-MAR-2031
Yield to maturity
—
Maturity date
Mar 15, 2031
ABBV5068389
AbbVie Inc. 4.85% 15-JUN-2044
Yield to maturity
—
Maturity date
Jun 15, 2044
ABBV6009611
AbbVie Inc. 4.65% 15-MAR-2028
Yield to maturity
—
Maturity date
Mar 15, 2028
ABBV5068387
AbbVie Inc. 4.25% 21-NOV-2049
Yield to maturity
—
Maturity date
Nov 21, 2049
ABBV5006799
AbbVie Inc. 4.85% 15-JUN-2044
Yield to maturity
—
Maturity date
Jun 15, 2044
ABBV5082874
AbbVie Inc. 4.55% 15-MAR-2035
Yield to maturity
—
Maturity date
Mar 15, 2035
ABBV5084327
AbbVie Inc. 3.2% 21-NOV-2029
Yield to maturity
—
Maturity date
Nov 21, 2029
ABBV5759196
AbbVie Inc. 5.5% 15-MAR-2064
Yield to maturity
—
Maturity date
Mar 15, 2064
A
ACT4218883
Allergan Funding SCS 4.75% 15-MAR-2045
Yield to maturity
—
Maturity date
Mar 15, 2045
ABBV5006798
AbbVie Inc. 4.55% 15-MAR-2035
Yield to maturity
—
Maturity date
Mar 15, 2035
ABBV5759204
AbbVie Inc. 5.35% 15-MAR-2044
Yield to maturity
—
Maturity date
Mar 15, 2044

See all ABBV bonds 

Sparks


Curated watchlists where ABBV is featured.

See all sparks 

Frequently Asked Questions


The current price of ABBV is 189.41 USD — it has decreased by −2.11% in the past 24 hours. Watch AbbVie, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BVL exchange AbbVie, Inc. stocks are traded under the ticker ABBV.
We've gathered analysts' opinions on AbbVie, Inc. future price: according to them, ABBV price has a max estimate of 260.00 USD and a min estimate of 170.00 USD. Watch ABBV chart and read a more detailed AbbVie, Inc. stock forecast: see what analysts think of AbbVie, Inc. and suggest that you do with its stocks.
ABBV reached its all-time high on Sep 6, 2024 with the price of 193.50 USD, and its all-time low was 160.10 USD and was reached on May 9, 2024. View more price dynamics on ABBV chart.
See other stocks reaching their highest and lowest prices.
ABBV stock is 2.16% volatile and has beta coefficient of 0.36. Track AbbVie, Inc. stock price on the chart and check out the list of the most volatile stocks — is AbbVie, Inc. there?
Today AbbVie, Inc. has the market capitalization of ‪373.87 B‬, it has decreased by −2.77% over the last week.
Yes, you can track AbbVie, Inc. financials in yearly and quarterly reports right on TradingView.
AbbVie, Inc. is going to release the next earnings report on Oct 24, 2025. Keep track of upcoming events with our Earnings Calendar.
ABBV earnings for the last quarter are 2.97 USD per share, whereas the estimation was 2.88 USD resulting in a 3.12% surprise. The estimated earnings for the next quarter are 3.26 USD per share. See more details about AbbVie, Inc. earnings.
AbbVie, Inc. revenue for the last quarter amounts to ‪15.42 B‬ USD, despite the estimated figure of ‪15.03 B‬ USD. In the next quarter, revenue is expected to reach ‪15.55 B‬ USD.
ABBV net income for the last quarter is ‪928.00 M‬ USD, while the quarter before that showed ‪1.28 B‬ USD of net income which accounts for −27.27% change. Track more AbbVie, Inc. financial stats to get the full picture.
Yes, ABBV dividends are paid quarterly. The last dividend per share was 1.64 USD. As of today, Dividend Yield (TTM)% is 3.06%. Tracking AbbVie, Inc. dividends might help you take more informed decisions.
AbbVie, Inc. dividend yield was 3.54% in 2024, and payout ratio reached 263.15%. The year before the numbers were 3.87% and 220.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 12, 2025, the company has ‪55 K‬ employees. See our rating of the largest employees — is AbbVie, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AbbVie, Inc. EBITDA is ‪26.75 B‬ USD, and current EBITDA margin is 44.40%. See more stats in AbbVie, Inc. financial statements.
Like other stocks, ABBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AbbVie, Inc. stock right from TradingView charts — choose your broker and connect to your account.